Literature DB >> 8164308

The effect of catheter type and site on infection rates in total parenteral nutrition patients.

L Kemp1, J Burge, P Choban, J Harden, J Mirtallo, L Flancbaum.   

Abstract

Infections pose a major problem in patients receiving total parenteral nutrition. Controversy continues concerning the effect of catheter type (triple-, double-, single-lumen, or pulmonary artery), insertion site (subclavian, internal jugular, or femoral vein), and the incidence of catheter-related infections. We retrospectively studied multi-lumen catheter use for total parenteral nutrition over a 6-month period in 192 patients, a total of 3334 catheter days. Nonintensive care unit catheters were inserted by the Nutrition Support Service, and intensive care unit catheters were inserted by the intensive care unit staff. All catheters were cared for using Nutrition Support Service protocols, with multi-lumen catheters changed every 7 to 10 days and pulmonary artery catheters changed every 4 days. Infections were determined by semiquantitative cultures (> 15 colonies/plate). The incidence of infections for triple-lumen catheters was 5 (subclavian), 17 (internal jugular), and 36% (femoral) respectively; total infection rate for triple-lumen catheters was 10%. Infection rates for pulmonary artery catheters were 4 (subclavian), and 6% internal (jugular site), respectively, the overall infection rate was 5%. There were no differences in infection rates at any site based on catheter type; however, when triple-lumen catheter sites were compared, the differences were significant (p < .001 vs subclavian, chi 2). Catheter duration was 7.8 days (subclavian),, 7.3 days (internal jugular), and 4.6 (femoral) days. These data suggest that the use of multi-lumen catheters for total parenteral nutrition is safe, that there is a benefit associated with the subclavian route, and that the femoral site should be avoided.

Entities:  

Mesh:

Year:  1994        PMID: 8164308     DOI: 10.1177/014860719401800171

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  7 in total

1.  Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit.

Authors:  Corsino Rey; Francisco Alvarez; Victoria De-La-Rua; Andrés Concha; Alberto Medina; Juan-José Díaz; Sergio Menéndez; Marta Los-Arcos; Juan Mayordomo-Colunga
Journal:  Intensive Care Med       Date:  2011-01-27       Impact factor: 17.440

2.  [Complications and adverse events in continuous peripheral regional anesthesia Results of investigations on 3,491 catheters].

Authors:  M Neuburger; J Breitbarth; F Reisig; D Lang; J Büttner
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

3.  Catheter-related bacteremia from femoral and central internal jugular venous access.

Authors:  L Lorente; A Jiménez; C García; R Galván; J Castedo; M M Martín; M L Mora
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04-02       Impact factor: 3.267

4.  [Abscess of the psoas muscle caused by a psoas compartment catheter. Case report of a rare complication of peripheral catheter regional anaesthesia].

Authors:  M Neuburger; D Lang; J Büttner
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

5.  History of right heart catheterization: 100 years of experimentation and methodology development.

Authors:  Bobby D Nossaman; Brittni A Scruggs; Vaughn E Nossaman; Subramanyam N Murthy; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644

6.  Central venous catheter-related bloodstream infections in the intensive care unit.

Authors:  Harsha V Patil; Virendra C Patil; M N Ramteerthkar; R D Kulkarni
Journal:  Indian J Crit Care Med       Date:  2011-10

Review 7.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.